8 Results for "

BZR

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "BZR" in MCE Product Catalog:

Art. -Nr.: HY-103476
CAS. Nr.: 91917-65-6
Reinheit:  99.17%
Target:  

GABA Receptor

Forschungsgebiete:  

Neurological Disease

Ro15-4513, imidazobenzodiazepinone derivative, is a partial inverse agonist of benzodiazepine receptor (BZR) . Ro15-4513 is a potent ethanol antagonist . Ro15-4513 has anti-anxiety effect . Ro15-4513 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
loading...
    loading...
Art. -Nr.: HY-106025
CAS. Nr.: 219846-31-8
Reinheit:  98.76%
Synonyms: AC-3933
Target:  

GABA Receptor

Forschungsgebiete:  

Neurological Disease

Radequinil (AC-3933) is a benzodiazepine receptor (BzR) partial inverse agonist. AC-3933 binds to GABA(-) and GABA(+) ligand with Kis of 5.15 and 6.11 nM, respectively .
loading...
    loading...
Art. -Nr.: HY-19082
CAS. Nr.: 118288-67-8
Target:  

GABA Receptor

Forschungsgebiete:  

Neurological Disease

Y-23684 is a partial agonist of benzodiazepine receptor (BZR) with anticonvulsant and anxiolytic activities. Y-23684 can be used in the research of treatment of anxiety disorders .
loading...
    loading...
Art. -Nr.: HY-103476R
CAS. Nr.: 91917-65-6
Forschungsgebiete:  

Neurological Disease

Ro15-4513 (Standard) is the analytical standard of Ro15-4513. This product is intended for research and analytical applications. Ro15-4513, imidazobenzodiazepinone derivative, is a partial inverse agonist of benzodiazepine receptor (BZR) . Ro15-4513 is a potent ethanol antagonist . Ro15-4513 has anti-anxiety effect . Ro15-4513 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
loading...
    loading...
Art. -Nr.: HY-103521
CAS. Nr.: 355022-97-8
Target:  

GABA Receptor

Forschungsgebiete:  

Neurological Disease

Anxiolytic/nonsedative agent-1 (compound 2b) is a potent and selective GABAA agonist. Anxiolytic/nonsedative agent-1 shows appreciable affinity for the BzR in bovine brain membranes with Kis of 14, 121, 239 nM for α1β2γ2, α2β2γ2, α5β3γ2, respectively. Anxiolytic/nonsedative agent-1 shows α2 selective efficacy in vitro and anxioselective effects in vivo .
loading...
    loading...
Art. -Nr.: HY-180955
CAS. Nr.: 773886-89-8
Forschungsgebiete:  

Neurological Disease

Desfluoro-BMS-694153 (Compound 3) is a calcitonin gene-related peptide receptor (CGRP receptor) antagonist, with a Ki value of 0.01 nM. Desfluoro-BMS-694153 has a significantly reduced risk of CYP3A4 inhibition, and its IC50 values for CYP3A4-BFC and CYP3A4-BZR are 36 and 6 μM respectively. Desfluoro-BMS-694153 can be used for research on migraines .
loading...
    loading...
Art. -Nr.: HY-106025R
CAS. Nr.: 219846-31-8
Synonyms: AC-3933 (Standard)
Forschungsgebiete:  

Neurological Disease

Radequinil (Standard) is the analytical standard of Radequinil (HY-106025). This product is intended for research and analytical applications. Radequinil (AC-3933) is a benzodiazepine receptor (BzR) partial inverse agonist. AC-3933 binds to GABA(-) and GABA(+) ligand with Kis of 5.15 and 6.11 nM, respectively .
loading...
    loading...
Art. -Nr.: HY-169651
CAS. Nr.: 61-38-1
Target:  

GABA Receptor

Forschungsgebiete:  

Neurological Disease

GABA-IN-4 (Compound 17) is a N-(indol-3-ylglyoxylyl)benzylamine derivative. GABA-IN-4 exhibits high affinity for the benzodiazepine receptor (BzR) (binding site in GABAA receptor complex) with Ki value of 67 nM. Benzodiazepines are widely used as antianxiety, sedative-hypnotic and anticonvulsant agents .
loading...
    loading...